Top Biotechnology companies in Poland by Net Cash Used Provided By Financing Activities
Poland
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 61.07 M
|
Dec. 31, 2023 | USD 6.53 | 2.36% |
|
Poland |
|
| 2 |
USD 13.88 M
|
Dec. 31, 2023 | USD 2.23 | -2.90% |
|
Poland |
|
| 3 |
USD 13.52 M
|
Dec. 31, 2023 | USD 1.13 | -2.47% |
|
Poland |
|
| 4 |
USD 9.37 M
|
Dec. 31, 2023 | USD 12.20 | -4.46% |
|
Poland |
|
| 5 |
USD 8.75 M
|
Dec. 31, 2023 | USD 2.23 | -2.59% |
|
Poland |
|
| 6 |
USD 6.14 M
|
Dec. 31, 2023 | USD 3.74 | -3.55% |
|
Poland |
|
| 7 |
USD 5.27 M
|
Dec. 31, 2023 | USD 9.53 | 2.20% |
|
Poland |
|
| 8 |
USD 5.17 M
|
Dec. 31, 2023 | USD 20.96 | 2.85% |
|
Poland |
|
| 9 |
USD 2.99 M
|
Dec. 31, 2023 | USD 1.76 | -3.29% |
|
Poland |
|
| 10 |
USD 1.64 M
|
Dec. 31, 2023 | USD 0.74 | -0.78% |
|
Poland |
|
| 11 |
USD 1.08 M
|
Dec. 31, 2023 | USD 3.36 | 11.39% |
|
Poland |
|
| 12 |
USD -175.23 K
|
Dec. 31, 2023 | USD 1.79 | -1.96% |
|
Poland |
|
| 13 |
USD -2.06 M
|
Dec. 31, 2023 | USD 0.86 | -4.13% |
|
Poland |
|
| 14 |
USD -2.35 M
|
Dec. 31, 2023 | USD 1.11 | -3.12% |
|
Poland |
|
| 15 |
USD -3.31 M
|
Dec. 31, 2023 | USD 2.81 | -1.43% |
|
Poland |
|
| 16 |
USD -5.22 M
|
Dec. 31, 2023 | USD 5.78 | -2.65% |
|
Poland |
|
| 17 |
USD -7.85 M
|
Dec. 31, 2023 | USD 10.51 | -3.97% |
|
Poland |
|
| 18 |
USD -8.67 M
|
Sept. 30, 2024 | USD 51.90 | -3.89% |
|
Poland |
|
| 19 |
USD -10.34 M
|
Dec. 31, 2023 | USD 5.23 | -1.43% |
|
Poland |
|
| 20 |
USD -12.14 M
|
Dec. 31, 2023 | USD 34.85 | -3.77% |
|
Poland |
|
| 21 |
USD -35.27 M
|
Dec. 31, 2023 | USD 206.65 | -0.03% |
|
Poland |
|
| 22 |
USD -59.40 M
|
Dec. 31, 2023 | USD 39.15 | -2.15% |
|
Poland |
Frequently Asked Questions
-
Which Biotechnology company in Poland has the highest Net Cash Used Provided By Financing Activities ?
The Biotechnology company in Poland with the highest Net Cash Used Provided By Financing Activities is Ryvu Therapeutics S.A. (Warsaw Stock Exchange: RVU.WA) at USD 61.07 M.
-
Which Biotechnology company in Poland has the lowest Net Cash Used Provided By Financing Activities ?
The Biotechnology company in Poland with the lowest Net Cash Used Provided By Financing Activities is Scope Fluidics S.A. (Warsaw Stock Exchange: SCP.WA) at USD -59.40 M.
-
What are the top 10 Biotechnology companies in Poland by Net Cash Used Provided By Financing Activities ?
The top 10 Biotechnology companies in Poland by Net Cash Used Provided By Financing Activities are Ryvu Therapeutics S.A., Molecure S.A., Synthaverse S.A., Captor Therapeutics Spolka Akcyjna, Mabion S.A., Pure Biologics Spólka Akcyjna, Poltreg S.A., Bioceltix S.A., Genomtec S.A. and NanoGroup S.A..
-
What are the bottom 10 Biotechnology companies in Poland by Net Cash Used Provided By Financing Activities ?
The bottom 10 Biotechnology companies in Poland by Net Cash Used Provided By Financing Activities are Scope Fluidics S.A., NEUCA S.A., Voxel S.A., Centrum Medyczne ENEL-MED S.A., Synektik Spólka Akcyjna, Selvita S.A., Celon Pharma S.A., EMC Instytut Medyczny SA, Pharmena S.A. and BIOTON S.A..
